Sunshine Biopharma Inc. Income Statement

Income Statement Jul2009 Dec2009 Dec2010 Dec2011 Dec2012 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.00M0.00M-0.03M-0.10M0.45M0.02M0.07M0.23M4.35M24.09M34.87M
Cost of Revenue 0.39M0.01M0.03M0.12M2.65M15.75M24.20M
Gross Profit 0.06M0.01M0.05M0.11M1.70M8.34M10.67M
Operating items
Amortization - Intangibles 0.00M0.06M0.01M0.00M0.01M0.01M
Depreciation & Amortization - Total 479.000.00M0.01M0.01M0.02M0.11M0.15M
Research & Development 0.14M0.00M0.01M0.03M0.01M0.02M0.00M0.67M0.81M1.86M0.93M
Selling, General & Administrative 1.20M0.54M0.56M0.71M0.78M0.99M0.86M1.22M0.65M0.62M2.55M28.70M13.12M16.48M
Restructuring Costs 0.01M708.002.14M3.11M
Other Operating Expenses -12.29M-26.16M
Operating Expenses 0.01M1.20M0.54M0.70M0.71M0.79M1.03M0.86M1.24M0.67M0.64M3.24M29.53M17.23M20.67M
Operating Income -0.71M-0.78M-0.99M-0.86M-1.17M-0.64M-0.58M-2.44M-27.00M-4.79M-5.81M
EBIT -0.71M-0.78M-0.99M-0.86M-1.17M-0.64M-0.58M-2.44M-27.00M-4.79M-5.81M
Non-operating items
Interest & Investment Income 0.00M0.00M
Other Non Operating Income -0.00M0.04M-0.02M0.01M0.05M0.01M-245.00-0.04M
Non Operating Income -0.87M-2.50M-0.18M-0.99M-0.44M-2.21M-10.00M0.49M0.67M0.44M
Net income details
EBT -0.71M-1.09M-1.03M-0.96M-1.33M-1.08M-2.78M-12.44M-26.51M-4.11M-5.37M
Tax Provisions 0.23M0.40M-0.23M
Profit After Tax 0.07M1.20M-0.54M-0.56M-0.71M-1.65M-3.50M-1.04M-2.16M-1.66M-2.78M-12.44M-26.74M-4.51M-5.13M
Income from Continuing Operations -0.71M-1.09M-1.03M-0.96M-1.33M-1.08M-2.78M-12.44M-26.74M-4.51M-5.13M
Consolidated Net Income -0.71M-1.09M-1.03M-0.96M-1.33M-0.58M-2.78M-12.44M-26.74M-4.51M-5.13M
Income towards Parent Company -0.71M-1.09M-1.03M-0.96M-1.33M-0.58M-2.78M-12.44M-26.74M-4.51M-5.13M
Net Income towards Common Stockholders -0.71M-1.09M-3.50M-1.04M-2.16M-1.66M-2.78M-12.44M-26.74M-4.51M-5.13M
Additional items
EPS (Basic) -0.02-0.02-0.01-0.01-0.01-0.02-0.04-0.15-2.73-4.76-0.00M-351.36-7.32
EPS (Weighted Average and Diluted) -4.76-1.76-351.36-7.32
Shares Outstanding (Weighted Average) 0.00M0.00M0.01M0.01M2.00M
Shares Outstanding (Diluted Average) 29.86M2.61M15.18M0.01M0.70M
EBITDA -0.71M-1.65M-3.50M-1.04M-2.16M-1.66M-2.78M-12.42M-26.56M-3.97M-6.66M
Interest Expenses 0.00M0.31M0.03M0.10M0.16M0.12M0.17M0.33M0.04M0.14M0.01M
Tax Rate 4.37%